Kailera Therapeutics (NASDAQ:KLRA) Director Andrew Kaplan Acquires 8,398,438 Shares of Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Andrew Kaplan bought 8,398,438 shares of the stock in a transaction on Monday, April 20th. The stock was purchased at an average cost of $16.00 per share, with a total value of $134,375,008.00. Following the acquisition, the director owned 26,255,581 shares in the company, valued at approximately $420,089,296. This represents a 47.03% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Kailera Therapeutics Stock Down 5.3%

Shares of KLRA stock opened at $24.61 on Tuesday. Kailera Therapeutics, Inc. has a 12 month low of $23.69 and a 12 month high of $28.23.